Dr. Eric C. Ma, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 28
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 392
Licensed in Connecticut since 2018, according to the Connecticut Department of Public Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
CT license 61788 (first issued 2018; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Danbury Hospital Danbury, CT
Medical groups
- Nuvance Health Medical Practice Ct Inc (747 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 392
- Services billed
- 1,922
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 906 | 246 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 569 | 148 |
| Insertion of needle into vein for collection of blood sample | 286 | 153 |
| Established patient office or other outpatient visit, 20-29 minutes | 159 | 102 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 99 | 37 |
| Urinalysis, manual test | 78 | 15 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 36 | 33 |
| New patient office or other outpatient visit, 45-59 minutes | 36 | 36 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 36 | 32 |
| New patient office or other outpatient visit, 60-74 minutes | 26 | 26 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Revlimid (lenalidomide) | 124 |
| Ondansetron Hcl Other prescribers in Danbury, CT | 85 |
| Acyclovir Other prescribers in Danbury, CT | 69 |
| Xarelto (rivaroxaban) Other prescribers in Danbury, CT | 60 |
| Eliquis (apixaban) Other prescribers in Danbury, CT | 58 |
| Allopurinol Other prescribers in Danbury, CT | 56 |
| Hydroxyurea Other prescribers in Danbury, CT | 55 |
| Potassium Chloride Other prescribers in Danbury, CT | 47 |
| Prednisone Other prescribers in Danbury, CT | 46 |
| Prochlorperazine Maleate Other prescribers in Danbury, CT | 41 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 32 companies reported 84 payments worth $4,425 in total to this clinician.
| Deciphera Pharmaceuticals Inc. | $2,637 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $216 |
| AbbVie Inc. | $174 |
| Array Biopharma Inc | $148 |
| Novartis Pharmaceuticals Corporation | $97.67 |
| Janssen Biotech, Inc. | $94.87 |
| Pfizer Inc. | $94.13 |
| Jazz Pharmaceuticals Inc. | $85.82 |
| Food and Beverage | $1,913 |
|---|---|
| Honoraria | $1,650 |
| Travel and Lodging | $862 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Deciphera Pharmaceuticals Inc. May 10, 2025 | Honoraria QINLOCK · ONCOLOGY | $1,650 |
| Deciphera Pharmaceuticals Inc. May 10, 2025 | Travel and Lodging QINLOCK · ONCOLOGY · travel to BOSTON, MA · in-kind | $581 |
| Deciphera Pharmaceuticals Inc. May 10, 2025 | Travel and Lodging QINLOCK · ONCOLOGY · travel to BOSTON, MA · in-kind | $281 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.